– Reuters
Enveric Biosciences Biorxiv Journal Article Just Published Titled “Novel Psilocin Prodrugs With Altered Pharmacological Properties As Candidate Therapies For Treatment-Resistant Anxiety Disorders”
https://www.biorxiv.org/content/10.1101/2023.05.16.540994v1
Abstract
The psychedelic compound psilocybin has shown therapeutic benefit in the treatment of numerous psychiatric diseases. A recent randomized clinical